NCT05151146View on ClinicalTrials.gov

A Phase 1 Study of ANJ900 Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

February 28, 2022

Conditions
Healthy
Interventions
DRUG

ANJ900

Metformin hydrochloride delayed-release tablets

DRUG

Metformin IR

metformin hydrochloride

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

Sponsors

Lead Sponsor

Anji Pharma
All Listed Sponsors
lead

Anji Pharma

INDUSTRY

NCT05151146 - A Phase 1 Study of ANJ900 Chinese Healthy Subjects | Biotech Hunter | Biotech Hunter